Feb 14, 2020
Wamberg Genomic Advisors Forms Advisory Board
Jan 13, 2019
Cancer Patient Report Released from Wamberg Genomic Advisors
Oct 25, 2018
More Than One in Three Cancer Patients Wished They Had Their Own Dedicated Cancer Expert to Advocate on Their Behalf--Wamberg Genomic Survey
Oct 16, 2018
Wamberg Genomic Advisors' Cancer Guardian, a Comprehensive Cancer Support Program, to Include the Color Clinical-Grade Genetic Test
Sep 18, 2018
Wamberg Genomic Advisors Inks Partnership with National Benefit Partners to Distribute Cancer Guardian, a Comprehensive Cancer Support Program, to Employers as a new Employee Benefit
Sep 12, 2018
Wamberg Genomic Advisors Announces The Penn Mutual Life Insurance Company to Provide Cancer Guardian as a Benefit to its Associates
Sep 10, 2018
Wamberg Genomic Advisors Expands its Cancer Guardian(TM) Program to Include Comprehensive Cancer Support, led by Cancer Support Specialists, Medical Record Management, and Advanced DNA Testing
Dec 21, 2017
62% of US Respondents Want Their Cancer Genetically Tested to Find New Treatments: Wamberg Genomic Survey
Dec 07, 2017
73% of Respondents Say One or More Diseases Run in Their Family; Just 6% Don't Want Genetic Testing -- Wamberg Genomic Survey
Nov 22, 2017
65% of Employees Would Pay for Genetic Testing from Their Employer Sponsored Health Account, Wamberg Genomic Survey
Nov 12, 2017
Wamberg Genomic Survey: 79% of Consumers Would Consider Genetic Testing to Limit Risk of Drug Side Effects
Sep 15, 2017
Wamberg Genomic Advisors Poll: 59% of Employee Benefit Executives Say Genomic Products are a Good Employee Benefit
Aug 20, 2017
Wamberg Genomic Advisors Launched to Provide Easy Access to Affordable Genomic Testing